Problem statement: Answer the multiple-choice question.
Query: Which drug has a 0.700\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: COc1ccc(N/N=C(/Oc2ccc([N+](=O)[O-])cc2)C(C)=O)cc1
b: C=CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc(O)c(CC)c1=O
c: COc1ccc(NC(=O)N2CCC3(CC2)OCCO3)cc1
Answer: b. C=CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc(O)c(CC)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc(O)c(CC)c1=O
C=CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc(O)c(CC)c1=O
N-(4-bromophenyl)-2-(5-ethyl-4-hydroxy-6-oxo-1-prop-2-enylpyrimidin-2-yl)sulfanylacetamide